Source: FEMS Immunology and Medical Microbiology. Unidade: FCFRP
Subjects: FARMACOLOGIA, ANTIDEPRESSIVOS, FÁRMACOS (EFEITOS), CÉLULAS DENDRÍTICAS, SEROTONINA
ABNT
BRANCO-DE-ALMEIDA, Luciana S. et al. Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes. FEMS Immunology and Medical Microbiology, v. 62, n. 3, p. 283-294, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1574-695X.2011.00816.x. Acesso em: 23 ago. 2024.APA
Branco-de-Almeida, L. S., Kajiya, M., Cardoso, C. R., Silva, M. J. B., Ohta, K., Rosalen, P. L., et al. (2011). Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes. FEMS Immunology and Medical Microbiology, 62( 3), 283-294. doi:10.1111/j.1574-695X.2011.00816.xNLM
Branco-de-Almeida LS, Kajiya M, Cardoso CR, Silva MJB, Ohta K, Rosalen PL, Franco GCN, Han X, Taubman MA, Kawai T. Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes [Internet]. FEMS Immunology and Medical Microbiology. 2011 ; 62( 3): 283-294.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1111/j.1574-695X.2011.00816.xVancouver
Branco-de-Almeida LS, Kajiya M, Cardoso CR, Silva MJB, Ohta K, Rosalen PL, Franco GCN, Han X, Taubman MA, Kawai T. Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes [Internet]. FEMS Immunology and Medical Microbiology. 2011 ; 62( 3): 283-294.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1111/j.1574-695X.2011.00816.x